InvestorsHub Logo
Followers 49
Posts 4963
Boards Moderated 0
Alias Born 02/05/2016

Re: None

Wednesday, 07/06/2022 9:34:59 AM

Wednesday, July 06, 2022 9:34:59 AM

Post# of 698380
New article about GBM in NEJM last week.

Virotherapy for Brain Tumors — Defining the Path to Success


Starts off saying:

Despite initial promise, immunotherapy with immune checkpoint inhibitors or peptide vaccines has failed to show efficacy in phase 3, randomized trials involving patients with glioblastoma,


I think you can eliminate NEJM from potential publishers of NWBO's manuscript.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News